Literature DB >> 14581311

Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit.

Paul W Armstrong1, Robert C Welsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14581311      PMCID： PMC219627     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  26 in total

1.  Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE).

Authors:  Kim A Eagle; Shaun G Goodman; Alvaro Avezum; Andrzej Budaj; Cynthia M Sullivan; José López-Sendón
Journal:  Lancet       Date:  2002-02-02       Impact factor: 79.321

Review 2.  New advances in the management of acute coronary syndromes: 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction.

Authors:  P W Armstrong
Journal:  CMAJ       Date:  2001-09-18       Impact factor: 8.262

3.  Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?

Authors:  Brahmajee K Nallamothu; Eric R Bates
Journal:  Am J Cardiol       Date:  2003-10-01       Impact factor: 2.778

4.  Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial.

Authors:  R V Luepker; J M Raczynski; S Osganian; R J Goldberg; J R Finnegan; J R Hedges; D C Goff; M S Eisenberg; J G Zapka; H A Feldman; D R Labarthe; P G McGovern; C E Cornell; M A Proschan; D G Simons-Morton
Journal:  JAMA       Date:  2000-07-05       Impact factor: 56.272

5.  Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome.

Authors:  M J Claeys; J Bosmans; L Veenstra; P Jorens; C J Vrints
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

6.  Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.

Authors:  L K Newby; E L Eisenstein; R M Califf; T D Thompson; C L Nelson; E D Peterson; P W Armstrong; F Van de Werf; H D White; E J Topol; D B Mark
Journal:  N Engl J Med       Date:  2000-03-16       Impact factor: 91.245

7.  Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.

Authors:  C P Cannon; C M Gibson; C T Lambrew; D A Shoultz; D Levy; W J French; J M Gore; W D Weaver; W J Rogers; A J Tiefenbrunn
Journal:  JAMA       Date:  2000-06-14       Impact factor: 56.272

8.  Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial.

Authors:  R Schröder; K Wegscheider; K Schröder; R Dissmann; W Meyer-Sabellek
Journal:  J Am Coll Cardiol       Date:  1995-12       Impact factor: 24.094

9.  A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.

Authors:  Henning R Andersen; Torsten T Nielsen; Klaus Rasmussen; Leif Thuesen; Henning Kelbaek; Per Thayssen; Ulrik Abildgaard; Flemming Pedersen; Jan K Madsen; Peer Grande; Anton B Villadsen; Lars R Krusell; Torben Haghfelt; Preben Lomholt; Steen E Husted; Else Vigholt; Henrik K Kjaergard; Leif Spange Mortensen
Journal:  N Engl J Med       Date:  2003-08-21       Impact factor: 91.245

10.  Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.

Authors:  Christopher B Granger; Kenneth W Mahaffey; W Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todaro; Jose C Nicolau; Witold Ruzyllo; Paul W Armstrong
Journal:  Circulation       Date:  2003-08-18       Impact factor: 29.690
View more
  2 in total

1.  Who was S. Weir Mitchell?

Authors:  Donald F Weaver
Journal:  CMAJ       Date:  2004-01-20       Impact factor: 8.262

Review 2.  Delivery of primary percutaneous coronary intervention for the management of acute ST segment elevation myocardial infarction: summary of the Cardiac Care Network of Ontario Consensus Report.

Authors:  Marino Labinaz; Terri Swabey; Randal Watson; Madhu Natarajan; Wendy Fucile; Bruce Lubelsky; Bruce Sawadsky; Eric Cohen; Kevin Glasgow
Journal:  Can J Cardiol       Date:  2006-03-01       Impact factor: 5.223
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.